Literature DB >> 16151786

[Polymyalgia rheumatica: myalgic syndrome or occult vasculitis?].

B Hellmich1, W L Gross.   

Abstract

Polymyalgia rheumatica (PMR) is a chronic inflammatory disorder of unknown etiology which typically presents with symmetric myalgias in the shoulder and pelvic girdles. Other clinical signs include the rapid onset of symptoms and the almost exclusive manifestation in the elderly population. In around 20% of cases, PMR is associated with giant cell arteritis (GCA). However, new imaging techniques suggest that the prevalence of subclinical GCA (e. g. aortitis) in PMR is probably higher. Acute phase reactants like erythrocyte sedimentation rate and c-reactive protein are usually elevated. Myalgias are accompanied by synovitis and bursitis of the large proximal joints and can be visualized by ultrasound or magnetic resonance imaging. While the diagnosis of GCA can be verified by temporal artery biopsy, pathognomonic findings for PMR like specific autoantibodies are lacking. Typical for PMR is the rapid response to corticosteroids. Usually the therapy needs to be continued for at least 2 years. Due to adverse events in many cases a corticosteroid saving therapy like methotrexate is needed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151786     DOI: 10.1007/s00108-005-1491-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  36 in total

1.  Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch.

Authors:  D Blockmans; S Stroobants; A Maes; L Mortelmans
Journal:  Am J Med       Date:  2000-02-15       Impact factor: 4.965

2.  Myalgic syndrome with constitutional effects; polymyalgia rheumatica.

Authors:  H S BARBER
Journal:  Ann Rheum Dis       Date:  1957-06       Impact factor: 19.103

3.  A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica.

Authors:  H A Bird; B F Leeb; C M Montecucco; N Misiuniene; G Nesher; S Pai; C Pease; J Rovensky; B Rozman
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

4.  Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study.

Authors:  F Cantini; C Salvarani; I Olivieri; L Niccoli; A Padula; L Macchioni; L Boiardi; G Ciancio; M Mastrorosato; F Rubini; A Bozza; G Zanfranceschi
Journal:  J Rheumatol       Date:  2001-05       Impact factor: 4.666

5.  Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.

Authors:  Carlo Salvarani; Fabrizio Cantini; Laura Niccoli; Pierluigi Macchioni; Dario Consonni; Gianluigi Bajocchi; Marco Vinceti; Maria Grazia Catanoso; Lia Pulsatelli; Riccardo Meliconi; Luigi Boiardi
Journal:  Arthritis Rheum       Date:  2005-02-15

6.  Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica.

Authors:  M Lopez-Hoyos; C Ruiz de Alegria; R Blanco; J Crespo; M Peña; V Rodriguez-Valverde; V M Martinez-Taboada
Journal:  Rheumatology (Oxford)       Date:  2004-02-17       Impact factor: 7.580

7.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

Review 8.  Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.

Authors:  Miguel A González-Gay; Mahsa M Amoli; Carlos Garcia-Porrua; William E r Ollier
Journal:  Semin Arthritis Rheum       Date:  2003-08       Impact factor: 5.532

9.  Initiation of glucocorticoid therapy: before or after temporal artery biopsy?

Authors:  Brian R Younge; Briggs E Cook; George B Bartley; David O Hodge; Gene G Hunder
Journal:  Mayo Clin Proc       Date:  2004-04       Impact factor: 7.616

10.  Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.

Authors:  C Salvarani; S E Gabriel; W M O'Fallon; G G Hunder
Journal:  Arthritis Rheum       Date:  1995-03
View more
  2 in total

1.  [Induction therapy with corticoid pulses for treatment of temporal arteritis].

Authors:  K Krüger
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

2.  [Infliximab is ineffective against giant cell arteritis and polymyalgia rheumatica].

Authors:  K Krüger
Journal:  Z Rheumatol       Date:  2007-10       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.